In June 2015, the US Food and Drug Administration (US FDA) ruled to ban trans fat from hundreds of foods. Food manufacturers, restaurants and others have until June 2018 to comply. While many have already been working to phase out trans fat from their products, others don’t think it will be that easy and are petitioning for some continued use.
The ban, as well as a business’ continued use of trans fat in products, could pose potential risks and XL Catlin’s Enterprise Risk Management and Casualty Risk Engineering teams continue to monitor the potential, watching for possible litigation against food/beverage manufacturers, distributors, suppliers and advertisers, as well as potential product recall actions as a result of the recent FDA decision. Trans fat continues to be an emerging risk that XL Catlin is watching.
OSHA guidance for recording COVID-19 cases among your workers
June 25, 2020
How do you deal with an employee who has COVID-19? Traditionally we don’t expect many communicable illnesses to be work-related. As we can all agree, COVID-19 has made reality more complex.
In April OSHA released initial enforcement guidelines for recording cases of COVID-19, which were broad with little
As the world adjusts to the changes brought about by the COVID-19 pandemic, one thing is certain – no company has been spared from the impact of a national shutdown and global business disruption. Equally, very few companies had included pandemic response of the type required in their business interruption
Playing our part; helping clients with their changing casualty risks
June 09, 2020
In these extraordinary times, companies in all sorts of industries are doing extraordinary things; both to help the global effort to beat COVID-19 and to help to ensure their own survival.
As companies adapt – and adapt quickly – to meet the challenges posed by the global pandemic, their liability exposures